Musaddiq Awan, MD

Publications

• Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations.

  (Hall WA, Mathison AJ, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, Awan M, Puckett LL, Lawton CAF, Schultz C, Urrutia R, Kerns S, Torres-Roca JF, Li XA, Erickson B, Nevalainen MT, Zimmermann MT, Paulson E.) Int J Radiat Oncol Biol Phys. 2024 Oct 01;120(2):570-578 PMID: 38819340 SCOPUS ID: 2-s2.0-85194948255 05/31/2024

• In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations.

  (Zenga J, Himburg HA, Wong SJ, Kearl T, Hematti P, Jin VX, Memon AA, Mathison AJ, Awan MJ.) Oral Oncol. 2024 Sep;156:106947 PMID: 39009483 SCOPUS ID: 2-s2.0-85198374252 07/16/2024

• Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.

  (Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA.) JAMA Oncol. 2024 Jul 01;10(7):896-904 PMID: 38780927 PMCID: PMC11117153 SCOPUS ID: 2-s2.0-85194249090 05/23/2024

• Type I interferon signaling promotes radioresistance in head and neck cancer.

  (Zenga J, Awan MJ, Frei A, Massey B, Bruening J, Shukla M, Sharma GP, Shreenivas A, Wong SJ, Zimmermann MT, Mathison AJ, Himburg HA.) Transl Cancer Res. 2024 May 31;13(5):2535-2543 PMID: 38881922 PMCID: PMC11170510 06/17/2024

• Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture.

  (Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA.) Transl Oncol. 2024 Apr;42:101899 PMID: 38320395 PMCID: PMC10851216 SCOPUS ID: 2-s2.0-85184507548 02/07/2024

• In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations

  (Zenga J, Himburg HA, Wong SJ, Kearl T, Hematti P, Jin VX, Memon AA, Mathison AJ, Awan MJ.) Oral Oncology. September 2024;156 SCOPUS ID: 2-s2.0-85198374252 09/01/2024

• Corrigendum to Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture (Translational Oncology (2024) 42, (S1936523324000251), (10.1016/j.tranon.2024.101899))

  (Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA.) Translational Oncology. June 2024;44 SCOPUS ID: 2-s2.0-85187349354 06/01/2024

• Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer

  (Lester SC, Moon DH, Patel SH, Awan MJ, Bakst RL.) International Journal of Radiation Oncology Biology Physics. 1 January 2024;118(1):165-168 SCOPUS ID: 2-s2.0-85178143715 01/01/2024

• Type I interferon signaling promotes radioresistance in head and neck cancer

  (Zenga J, Awan MJ, Frei A, Massey B, Bruening J, Shukla M, Sharma GP, Shreenivas A, Wong SJ, Zimmermann MT, Mathison AJ, Himburg HA.) Translational Cancer Research. 2024;13(5):2535-2543 SCOPUS ID: 2-s2.0-85195040296 01/01/2024

• Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.

  (Lester SC, Moon DH, Patel SH, Awan MJ, Bakst RL.) Int J Radiat Oncol Biol Phys. 2024 Jan 01;118(1):165-168 PMID: 38049222 SCOPUS ID: 2-s2.0-85178143715 12/05/2023

• Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.

  (Quashie EE, Li XA, Prior P, Awan M, Schultz C, Tai A.) Phys Med Biol. 2023 Dec 11;68(24) PMID: 37903437 SCOPUS ID: 2-s2.0-85180013067 10/31/2023

• Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer.

  (Zenga J, Awan M, Hadi Razeghi Kondelaji M, Hansen C, Shafiee S, Frei A, Foeckler J, Kuehn R, Bruening J, Massey B, Wong S, Joshi A, Himburg HA.) Oral Oncol. 2023 Sep;144:106487 PMID: 37423200 PMCID: PMC10413333 SCOPUS ID: 2-s2.0-85164978149 07/10/2023